AGP Executive Report
Last update: 7 hours agoKratom Crackdown: Massachusetts is moving fast to restrict kratom, with Gov. Healey issuing an emergency order and local bans following—aimed at products sold in smoke shops and gas stations that regulators say are largely unregulated and can vary in potency. CBD & Hemp Advertising Scrutiny: UK regulators put Katie Price-linked “Supreme CBD” on a non-compliant advertisers list over repeated claims that CBD treats or prevents conditions like anxiety, insomnia, and depression. Medical Cannabis Research (Canada): Canada announced a $24M research push through a national cannabis-and-brain-health consortium to study how cannabis affects mental health and wellbeing across key groups like youth and frequent users. Clinical CBD/Cannabis Science: A new study from UCSF found habitual cannabis inhalers had about 9% fewer premature heartbeats on use days vs abstinent days, adding to the debate over cannabis’s short-term heart effects. Industry Watch: Avicanna reported improved Q2 2026 financials and progress toward commercializing its QUIX™ portfolio. Safety & Policy: A UK case warned a man facing prison after police found 206g of cannabis, with the judge stressing personal accountability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
